A Computational Genomics, Epigenetic Inheritance, and Intersex Variation Synthesis

Section 1: Genetic Architecture and Polygenic Risk for Gender Incongruence

Gender incongruence has a measurable genetic component, primarily polygenic in nature. Twin studies consistently show higher concordance in monozygotic versus dizygotic pairs, with heritability estimates ranging from 11% to over 60% depending on cohort and phenotype definition (Conabere et al., 2025; Heylens et al., 2012).

Molecular studies identify variants in sex-steroid signaling genes (e.g., ESR1, SRD5A2) and neurodevelopmental pathways that influence brain sexual differentiation. These variants can alter how the fetal brain responds to prenatal hormones, contributing to divergence between physical sex and internal gender sense (Foreman et al., 2019; Theisen et al., 2019).

Section 2: Hereditary Trauma and Epigenetic Inheritance

Hereditary trauma refers to epigenetic modifications transmitted across generations. Prenatal exposure to maternal stress, infection, or trauma can induce DNA methylation and histone changes that persist in offspring, affecting stress response systems, sensory processing, and self-perception networks.

Systematic reviews link maternal prenatal distress to altered fetal brain development in regions involved in body awareness and social cognition (Walsh et al., 2020; Glover, 2011). These epigenetic marks can be inherited, creating transgenerational vulnerability to neurodevelopmental variations, including atypical gender-related self-perception.

Case studies of families with histories of trauma show increased rates of neurodevelopmental and gender-related diversity, supporting the role of epigenetic inheritance in shaping inborn traits.

Section 3: Intersex Conditions, Genetic Mutations, and Gender Incongruence

Intersex variations (Differences of Sex Development, DSD) provide direct evidence of genetic mutations influencing sexual differentiation. Conditions such as Congenital Adrenal Hyperplasia (CAH), Androgen Insensitivity Syndrome (AIS), and 5α-reductase deficiency involve mutations in genes regulating hormone synthesis or receptor function.

Many individuals with certain intersex conditions report elevated rates of gender incongruence. For example, some 46,XX CAH individuals raised female experience gender dysphoria, linked to prenatal androgen exposure altering brain development (Hines, 2015; Berenbaum, 2016).

Genetic mutations in intersex pathways (e.g., AR, SRD5A2) can produce atypical brain-body mapping, serving as a model for understanding non-intersex gender incongruence as part of a broader spectrum of sexual differentiation variations.

Section 4: Integrative Pathway Model

Inborn gender incongruence can be conceptualized as emerging from the interaction of:

• Polygenic risk affecting sex-steroid signaling and neurodevelopmental wiring.
• Epigenetic inheritance from parental trauma or stress, modulating gene expression in self-perception networks.
• Rare genetic mutations or intersex-related variants that shift developmental trajectories.

Case studies across DSD populations and families with hereditary trauma consistently show higher rates of gender incongruence, supporting this as a scientific reality rather than purely psychosocial phenomenon.

Section 5: Clinical and Research Implications

This model emphasizes probabilistic, multifactorial origins. It supports comprehensive evaluation including family history, prenatal factors, and neurodevelopmental assessment. Future GWAS and epigenetic studies will further map these pathways.